- Diabetes is the ninth leading cause of death in women globally - Novartis supports World Diabetes Day campaign urging women to prioritise healthy lifestyles Johannesburg, 13 November, 2017 – Ahead of World Diabetes Day on 14 November, Novartis South Africa has called on women to make themselves aware of diabetes risk factors and take steps to improve their health and that of their families. Diabetes mellitus (diabetes) is a growing health risk for both men and women around the world. With this year’s World Diabetes Day focus on women, the International Diabetes Federation notes that there are currently over 199 million women living with diabetes worldwide, with this number projected to increase to 313 million by 20401. Diabetes is the ninth leading cause of death in women globally, causing 2.1 million deaths each year1. Two out of every five women with diabetes are of reproductive age1, accounting for over 60 million women at increased risk of difficulty conceiving and poor pregnancy outcomes due to their diabetes1. Across Africa, the regional prevalence of diabetes was 3.2%, expected to increase to 3.7% by 2040. This region has the highest proportion (66.7%) of undiagnosed diabetes, and over the past few decades, diabetes has emerged as an important non-communicable disease (NCD) in sub-Saharan Africa, according to the Society for Endocrinology, Metabolism and Diabetes of South Africa (SEMDSA)2. In South Africa, the International Diabetes Federation (IDF) estimates that over 2.3 million people have diabetes but around 61% of them are undiagnosed2. In addition, the prevalence of diabetes in rural dwellers is increasing rapidly, with the Asian and Coloured populations having the highest prevalence of diabetes in South Africa2. Diabetes is a leading cause of death among women, yet the risk of developing diabetes as well as the risk of premature death among people with diabetes can be significantly reduced through proper management. “There are . . .
Midrand: World Diabetes Day takes place on 14th November this year - an opportunity for people from all walks of life to unite in raising awareness to improve the lives of those with diabetes and those at risk. If you are 35 years or older, overweight, especially around your waistline, and loathe doing exercise, you may well be at risk of developing Type 2 diabetes.2 The risk is increased if you also have high blood pressure or elevated cholesterol levels, or a family history of diabetes.2 According to the International Diabetes Federation there were 2.28 million cases of diabetes in South Africa in 2015.3 Type 2 diabetes is the most common form of diabetes, with more than 90% of diabetic patients suffering from this form of the disease.4 Type 2 diabetes is a disorder of a person's metabolism, and its primary characteristic is high blood glucose.5 The reasons for the high blood glucose are insulin resistance and lack of insulin.5 Type 2 diabetes is controlled through exercise and meal planning and may require diabetes tablets and /or insulin to assist the body in making or using insulin more effectively. 2 A well-established first-line medication for Type 2 diabetes is metformin.4 Metformin both lowers glucose production in the liver and improves glucose utilisation.4 Despite the benefits of the medication, it is quite possible that during treatment essential nutrients may be depleted as a result of diabetes and the treatment thereof. 6 Adcock Ingram has recently launched the GAP range of supplements, which has been specifically formulated to replenish vitamins and minerals that have been depleted as a result of chronic diseases or the treatment thereof. GLUCO-GAP assists in the maintenance of the essential nutrients that may be depleted as a result of diabetes and the treatment thereof.6 GLUCO-GAP contains HydroQsorb CoQ10. Co-enzymeQ10 acts as an antioxidant and is decreased in diabetic patients.6 Co-enzymeQ10 also seems to have a positive effect . . .